ExRNAs as Biomarkers for Placental DysfunctionFriday, 19 September 2014 at 16:15 Add to Calendar ▼2014-09-19 16:15:002014-09-19 17:15:00Europe/LondonExRNAs as Biomarkers for Placental DysfunctionExosomes and Single Cell Analysis Summit in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com Placental dysfunction, most commonly manifested as preeclampsia or intrauterine growth restriction, is an important cause of maternal and fetal morbidity and mortality in both the developing and developed world. It is thought that placental dysfunction arises from abnormal trophoblast differentiation and/or invasion, events that occur in the first trimester of pregnancy, but become clinically apparent only in the late second and third trimesters. Optimal surveillance and management of placental dysfunction, as well as the development of effective therapies, have been hampered by the lack of methods for early and accurate identification of pregnancies at risk for this disorder. We will discuss pregnancy-specific ExRNA profiles and the potential for ExRNAs as biomarkers for placental dysfunction and other adverse pregnancy outcomes. |